leisure time -WSS

leisure time

author：entertainment 2025-10-01 00:46:26 - browse：24914

Scanned cerebellum of a mouse brain, affected by Niemann-Pick Type C, shown in pink and teal — biotech coverage from STAT — The cerebellum of a mouse brain affected by Niemann-Pick Type C. Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health

About a decade ago, Tatiana Bremova-Ertl’s graduate adviser was studying an obscure, 1950s-era French vertigo drug, probing its effects on people with balance disorders, when she thought of another, very sick group of patients.

A graduate student and medical resident at the German Center for Vertigo and Balance Disorders, in Munich, Bremova-Ertl often saw patients with Niemann-Pick Type C, a rare, genetic disease that slowly kills neurons.

NPC has a range of manifestations. When symptoms appear in early childhood, it is often fatal before adulthood. When it manifests later, it can be milder. But it’s always degenerative and leads to a cluster of challenges: cognitive decline, difficulty with speech and swallowing, enlarged liver, low muscle tone, and, notably, difficulty with balance and muscle control. Researchers and a fervent group of parents were working to develop medicines, but little had yet worked.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Medicare Advantage proposed rates disappoint insurers

focus

WSS

Robert F. Kennedy is pitching centrism on health, even on abortion

Apple Vision Pro: A first look at health apps on the new VR headset

Key House Republican on health care plans exit from Congress

Robert F. Kennedy is pitching centrism on health, even on abortion

What we need to know about Arena Bioworks

Industry veterans launch new biotech VC with $310M

leisure time

leisure time

entertainment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The dental labor crisis is a moment of opportunity

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Quicker fix for pulse oximeters urged during FDA public meeting

State Dept. review finds Biden bears some blame for Afghanistan failures

A $475,000 price tag for a new cancer drug: crazy or meh?

Tori Bowie and the unacceptable rates of Black maternal death

Some dementia cases could be undiagnosed liver disease

Walensky prepares to leave CDC — and Congress — behind

A disappointing year of Humira biosimilars

explore

Cognito secures funding to test medical device for Alzheimer's

The Readout: Gilead, Bernie Sanders, and other pharma news

Vaccine advisory panel ACIP left half staffed by HHS

Key House Republican on health care plans exit from Congress

How digital tools helped lower hypertension in marginalized patients

Biogen Alzheimer’s drug launch off to slow start

leisure time

focus

focus

hotspot